Serotonin-3 Receptor Antagonist

This page covers all Serotonin-3 Receptor Antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 3A.

Targets

5-hydroxytryptamine receptor 3A

Marketed (2)

• Anzemet · Validus Pharms · Other
• Lotronex · Legacy Pharma · Neuroscience
  Lotronex works by blocking serotonin receptors in the gut to slow down bowel movements.

Patent intelligence

• serotonin 3 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates